Massachusetts faced some of the heaviest losses nationally, with cuts affecting more than $100 million in NIH grants.

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg (Niaspan ...

The product is bioequivalent and therapeutically equivalent to the reference listing drug VYZULTA Opthalmic solution, 0.024% ...

Health and Human Services employees were told in March to remove nicknames from email systems and signatures to comply with ...

In recent weeks, top health officials have floated an idea for bringing down prescription drug costs in the United States: ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Heeding the call to ban artificial ingredients by Health and Human Services Secretary Robert F. Kennedy Jr., PepsiCo isn’t ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

Media reports and social media influencers have caused consumers to question the use of seed oils, such as soybean, corn, ...

AI can be a powerful tool in research, but it's not the be-all, end-all—and a new study led by Amer Alam, PhD, associate professor at The Hormel Institute, University of Minnesota, is a prime example ...

Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...

On April 22, the Department of Health and Human Services and the Food and Drug Administration announced measures designed to ...